相关实验视频
Updated: Jun 11, 2025

07:37
An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
Published on: June 6, 2025
43
关于难以确定类风湿性关节炎临床实践的预后因素的困难
Olivier Vittecoq1, Pauline Brevet2, Baptiste Gerard2
1Rheumatology Department, University Hospital Centre Rouen, Rouen, Normandie, France vittecoq.olivier@wanadoo.fr.
RMD open
|September 29, 2024
概括
在类风湿性关节炎 (RA) 中确定预后因素 (PF) 对于个性化治疗至关重要. 挑战包括各种定义和疾病阶段,需要先进的分析工具来准确预测疾病和治疗结果.
科学领域:
- 类风湿病学 类风湿病学
- 临床免疫学临床免疫学
- 精准医学是一门精准的医学.
背景情况:
- 预后因素 (PF) 对于类风湿性关节炎 (RA) 关于疾病结果和治疗反应的决策至关重要.
- 目前对PF的鉴定受到预后和疾病异质性的非唯一定义的阻碍.
- 现有的方法往往无法考虑疾病持续时间,时间变化和治疗影响.
研究的目的:
- 为了解决识别类风湿性关节炎可靠预后因素的复杂性.
- 突出需要综合方法和先进的数据分析,精确医学在RA.
- 改善预测RA患者的疾病进展和治疗成功.
主要方法:
- 审查在RA的预后因素识别现有的挑战.
- 分析影响预后预测准确性的因素.
- 强调对纵向数据和多领域方法的需求.
主要成果:
- 定义预后和疾病实体的异质性使PF识别变得复杂.
- 单一时间点测量和不充分考虑疾病阶段极限的预测准确性.
- 利用大规模数据分析的综合方法对于推进RA精准医学至关重要.
结论:
- 在RA中准确的预后因素识别需要解决定义不一致性和方法限制.
- 未来的研究必须包含纵向数据,疾病持续时间和先进的分析工具.
- 改进的预后因素识别将使风湿性关节炎的更个性化和更有效的管理成为可能.
更多相关视频
相关概念视频
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
8
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
8
Rheumatic Heart Disease IV: Nursing Management
5
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
5
Rheumatic Heart Disease III: Medical Management
3
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
3
Rheumatic Heart Disease I: Introduction
3
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
3
The JAK-STAT Signaling Pathway
8.7K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
8.7K
Coronary Artery Disease I: Introduction
3
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
3

